Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lees

Showing results (81-90 of 183) with videos related to

Pageof 19
Sort By:
Neurobiology of Disease|June 11, 2013
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesAdamantios Mamais, Meera Raja, Claudia Manzoni, et al.
Cellular Immunology|June 1, 2005
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activityGoutam Sen, Michael Flora, Gouri Chattopadhyay, et al.
Phytotherapy Research : PTR|January 26, 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's diseaseRia Fisher, Louise Lincoln, Michael J Jackson, et al.
DNA and Cell Biology|November 30, 2006
Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugatesAnahit Ghochikyan, Irina Petrushina, Andrew Lees, et al.
Neurobiology of Aging|May 14, 2013
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPTHelen Ling, Eleanna Kara, Rina Bandopadhyay, et al.
Journal of Parkinson'S Disease|September 10, 2019
Safety Profile of Opicapone in the Management of Parkinson's DiseaseAndrew Lees, Joaquim J Ferreira, José-Francisco Rocha, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2009
Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal diseaseRachel A Foster, Jennifer Carlring, Michael W McKendrick, et al.
Movement Disorders Clinical Practice|October 27, 2018
Do Parkinson's Disease Patients Have Deficits in Sequential Sampling Tasks?Atbin Djamshidian, Jennifer Mulhall, Alessandro Tomassini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Risk and learning in impulsive and nonimpulsive patients with Parkinson's diseaseAtbin Djamshidian, Ashwani Jha, Sean S O'Sullivan, et al.
Immunology|September 23, 2014
Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linkingLorena Preciado-Llanes, James B Wing, Rachel A Foster, et al.
Pageof 19

Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
Neurobiology of Disease|June 11, 2013
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesAdamantios Mamais, Meera Raja, Claudia Manzoni, et al.
Cellular Immunology|June 1, 2005
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activityGoutam Sen, Michael Flora, Gouri Chattopadhyay, et al.
Phytotherapy Research : PTR|January 26, 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's diseaseRia Fisher, Louise Lincoln, Michael J Jackson, et al.
DNA and Cell Biology|November 30, 2006
Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugatesAnahit Ghochikyan, Irina Petrushina, Andrew Lees, et al.
Neurobiology of Aging|May 14, 2013
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPTHelen Ling, Eleanna Kara, Rina Bandopadhyay, et al.
Journal of Parkinson'S Disease|September 10, 2019
Safety Profile of Opicapone in the Management of Parkinson's DiseaseAndrew Lees, Joaquim J Ferreira, José-Francisco Rocha, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2009
Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal diseaseRachel A Foster, Jennifer Carlring, Michael W McKendrick, et al.
Movement Disorders Clinical Practice|October 27, 2018
Do Parkinson's Disease Patients Have Deficits in Sequential Sampling Tasks?Atbin Djamshidian, Jennifer Mulhall, Alessandro Tomassini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Risk and learning in impulsive and nonimpulsive patients with Parkinson's diseaseAtbin Djamshidian, Ashwani Jha, Sean S O'Sullivan, et al.
Immunology|September 23, 2014
Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linkingLorena Preciado-Llanes, James B Wing, Rachel A Foster, et al.
Pageof 19